Loading…
5 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| FRANCE-PLAST | Industrial Goods | 25.2% | 84th pct | 534 |
| Shota 2012 | Industrial Goods | 4.7% | 28th pct | 534 |
| Medegi Group | Industrial Goods | -0.1% | 14th pct | 534 |
| Elba Group | Industrial Goods | — | no FY data | 534 |
| Kvartsi Sakartvelo | Industrial Goods | — | no FY data | 534 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
Only 3 of 5 peers filed FY2024. Switch to FY2018 (4 of 5).
| Ratio — FY 2024 | FRANCE-PLAST | Medegi Group | Shota 2012 | Elba Group | Kvartsi Sakartvelo |
|---|---|---|---|---|---|
| Margins | |||||
| Gross Margin | 61.2% | 17.9% | 10.2% | — | — |
| EBITDA Margin | 25.2% | -0.1% | 4.7% | — | — |
| EBITDAR | 461 | -2 | 107 | — | — |
| EBITDAR Margin | 25.9% | -0.1% | 6.1% | — | — |
| EBIT Margin | 13.3% | -8.3% | 4.0% | — | — |
| Net Profit Margin | 16.8% | -20.1% | 2.5% | — | — |
| Operating Expense % of Sales | 36.0% | 18.0% | 5.5% | — | — |
| Returns | |||||
| Return on Assets (ROA) | 5.5% | -14.2% | 2.2% | — | — |
| Return on Equity (ROE) | 12.1% | N/A | 2.7% | — | — |
| ROIC [EBIT / Invested Capital] | 5.6% | -6.4% | 3.8% | — | — |
| Leverage & debt balances | |||||
| Debt-to-Assets | 33.4% | 114.9% | 13.3% | — | — |
| Debt-to-Equity | 0.73x | -4.88x | 0.16x | — | — |
| Debt-to-EBITDA | 4.01x | N/A | 3.17x | — | — |
| Equity-to-Assets | 45.7% | -23.5% | 81.9% | — | — |
| Net Debt | 1,739 | 2,870 | 236 | — | — |
| Cash & Equivalents | 61 | 4 | 26 | — | — |
| Total Debt | 1,800 | 2,875 | 261 | — | — |
| Liquidity & working capital | |||||
| Current Ratio | 1.59x | 2.71x | 20.28x | — | — |
| Quick Ratio | 1.59x | 1.68x | 20.28x | — | — |
| Cash Ratio | 0.05x | 0.01x | 0.28x | — | — |
| Total Current Assets | 1,794 | 1,177 | 1,872 | — | — |
| Total Current Liabilities | 1,127 | 435 | 92 | — | — |
| Inventory | N/A | 448 | N/A | — | — |
| Trade Receivables | 1,096 | 142 | 819 | — | — |
| Trade Payables | 1,039 | 172 | 4 | — | — |
| Net Working Capital | 667 | 742 | 1,780 | — | — |
| Net Working Capital % of Revenue | 37.5% | 42.1% | 101.9% | — | — |
| Trade Working Capital | 58 | 419 | 814 | — | — |
| Trade Working Capital % of Revenue | 3.2% | 23.7% | 46.6% | — | — |
| Change in Trade Working Capital | N/A | N/A | N/A | — | — |
| Turnover & efficiency | |||||
| Inventory Turnover | N/A | 3.23x | N/A | — | — |
| Days Inventory Outstanding (DIO) | N/A | 113.0 | N/A | — | — |
| Receivables Turnover | 1.62x | 12.41x | 2.13x | — | — |
| Days Sales Outstanding (DSO) | 224.7 | 29.4 | 171.1 | — | — |
| Payables Turnover | 0.66x | 8.44x | 380.62x | — | — |
| Days Payable Outstanding (DPO) | 549.0 | 43.3 | 1.0 | — | — |
| Cash Conversion Cycle | -324.3 days | 99.2 days | 170.1 days | — | — |
| Asset Turnover | 0.33x | 0.70x | 0.89x | — | — |
| Cash flow & dividends | |||||
| Operating Cash Flow | N/A | -281 | 1,820 | — | — |
| Free Cash Flow (OCF − Capex proxy) | N/A | -1,242 | 2,095 | — | — |
| Cash Conversion (OCF / EBITDA) | N/A | N/A | 2205.8% | — | — |
| Dividends Declared | N/A | 0 | N/A | — | — |
| Dividend Payout Ratio | N/A | N/A | N/A | — | — |